Evidence map›Paper›PMID 33769627›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2021

Acetylenic Replacement of Albicidin's Methacrylamide Residue Circumvents Detrimental E/Z Photoisomerization and Preserves Antibacterial Activity.

Iraj Behroz, Leonardo Kleebauer, Kay Hommernick, Maria Seidel, Stefan Grätz, Andi Mainz, John B Weston, Roderich D Süssmuth

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Optical Modulation of Antibiotic Resistance by Photoswitchable Cystobactamids.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Iraj BehrozInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
Leonardo KleebauerInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
Kay HommernickInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
Maria SeidelInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
Stefan GrätzInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
Andi MainzInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
John B WestonInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.
Roderich D SüssmuthInstitut für Organische Chemie, Technische Universität Berlin, Straße des 17. Juni 124, 10623, Berlin, Germany.ORCID http://orcid.org/0000-0001-9584-8642
Technische Universität Berlin · DE

Funding

Bundesministerium für Bildung und Forschung VIP grant 03VP00030Deutsche Forschungsgemeinschaft PE 2600/1-1Deutsche Forschungsgemeinschaft RTG 2473 "Bioactive Peptides"Deutsche Forschungsgemeinschaft SU 239/11-1
6 · The paper itself

Abstract

The natural product albicidin is a highly potent inhibitor of bacterial DNA gyrase. Its outstanding activity, particularly against Gram-negative pathogens, qualifies it as a promising lead structure in the search for new antibacterial drugs. However, as we show here, the N-terminal cinnamoyl moiety of albicidin is susceptible to photochemical E/Z isomerization. Moreover, the newly formed Z isomer exhibits significantly reduced antibacterial activity, which hampers the development and biological evaluation of albicidin and potent derivatives thereof. Hence, we synthesized 13 different variants of albicidin in which the vulnerable para-coumaric acid moiety was replaced; this yielded photostable analogues. Biological activity assays revealed that diaryl alkyne analogues exhibited virtually undiminished antibacterial efficacy. This promising scaffold will therefore serve as a blueprint for the design of a potent albicidin-based drug.

Indexed as

AlkynesXanthomonasAcrylamidesAnti-Bacterial AgentsMicrobial Sensitivity TestsOrganic ChemicalsStructure-Activity RelationshipAcrylamidesalbicidinAlkynesAnti-Bacterial AgentsmethacrylamideOrganic Chemicalsantibioticsbiological activitydrug discoverymedicinal chemistrystructure-activity relationships

Identifiers

PMID33769627
PMCPMC8362182
OpenAlexW3136658675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.